Hippocampus-dependent cognitive enhancement induced by systemic gintonin administration

BACKGROUND: A number of neurological and neurodegenerative diseases share impaired cognition as a common symptom. Therefore, the development of clinically applicable therapies to enhance cognition has yielded significant interest. Previously, we have shown that activation of lysophosphatidic acid re...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sungmin, Kim, Min-Soo, Park, Kwanghoon, Kim, Hyeon-Joong, Jung, Seok-Won, Nah, Seung-Yeol, Han, Jung-Soo, Chung, ChiHye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703807/
https://www.ncbi.nlm.nih.gov/pubmed/26843822
http://dx.doi.org/10.1016/j.jgr.2015.05.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703807/
https://www.ncbi.nlm.nih.gov/pubmed/26843822
http://dx.doi.org/10.1016/j.jgr.2015.05.001

Ejemplares similares